Invest in the Rocky Mountain Region
• Meet one-on-one with top bioscience companies in the Rocky Mountain region.
• Evaluate fresh investment opportunities
Venture capital investments in Colorado bioscience companies totaled $1.625 billion in the last five years with an additional $10.166 billion in acquisitions.
Over $1billion in investment in the region
Colorado 42 companies - $646.35M
Utah 18 companies - $170.32M
Arizona 15 companies - $110.28M
New Mexico 6 companies - $70.23M
Montana 2 companies - $26.8M
2009-2012 Totals
State Highlights
Arizona
Roche’s $3.4 billion acquisition of Ventana Medical Systems - 2008
Celgene to Acquire Abraxis Bioscience in $2.9 Billion Deal - 2010
Colorado
Accelr8 Attracts Up To $35 Million Private Equity Investment - 2012
miRagen Therapeutics Secures $20 Million Series B Financing - 2012
Montana
Takeda to Acquire LigoCyte Pharmaceuticals, Inc. $60 Million - 2012
Bacterin Secures $25 Million Financing with OrbiMed - 2012
